According to the Discounted Future Cash flow calculation, the price is fairly (almost 40%) below intrinsic value,
After achieving approval all these DFC calculation will be impacted by the strong response from the European market,
we don't need to be magician to predict what is going to happen to this Beautiful,
for more information, refer to the CEO interview by the famous The Australian commentator at eurekareport,
disallowed link/investment-news/starpharma-prepares-to-launch-covid-killing-nasal-spray/149289
According to the Discounted Future Cash flow calculation, the...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.001(1.02%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 9.6¢ | 10.0¢ | 9.6¢ | $5.703K | 58.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 9.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.8¢ | 20000 | 1 |
View Market Depth
| Last trade - 15.41pm 11/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |